Stock LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lixte Biotechnology Holdings, Inc.

Equities

LIXT

US5393193017

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-16 pm EDT 		5-day change 1st Jan Change
2.37 USD -1.66% Intraday chart for Lixte Biotechnology Holdings, Inc. +5.33% +0.85%
Jun. 14 Lixte Biotechnology Holdings, Inc. to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial CI
Jun. 06 Lixte Biotechnology Holdings, Inc. Reports Findings Show LIXTE's Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Stock Lixte Biotechnology Holdings, Inc.
 5.33M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 47.96B -
LONZA GROUP AG Stock Lonza Group AG
 41.47B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.45B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.6B -
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 28.63B
  1. Stock Market
  2. Equities
  3. LIXT Stock
  4. Charts Lixte Biotechnology Holdings, Inc.
  5. Sector Chart